CD45RA+ T cell-depleted allogeneic peripheral blood stem cell graft
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD45RA+ T cell-depleted allogeneic peripheral blood stem cell graft, covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children [Phase 2]